FLAM
EWTX icon

First Light Asset Management’s Edgewise Therapeutics EWTX Stock Holding History

First Light Asset Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.5M Buy
1,095,171
+93,325
+9% +$3.22M 2.7% 16
2026
Q1 		$31.6M Sell
1,001,846
-571,855
-36% -$16.5M 2.83% 12
2025
Q4 		$39.1M Buy
1,573,701
+158,707
+11% +$3.19M 2.99% 11
2025
Q3 		$23M Sell
1,414,994
-299,025
-17% -$4.24M 2.16% 18
2025
Q2 		$22.5M Sell
1,714,019
-138,271
-7% -$1.99M 2.91% 13
2025
Q1 		$40.8M Buy
1,852,290
+1,071,651
+137% +$28.1M 4.65% 8
2024
Q4 		$20.8M Buy
+780,639
New +$24.9M 1.99% 18

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Light Asset Management's EWTX Position: Q2 2026 in Review

First Light Asset Management increased its Edgewise Therapeutics (EWTX) stake by 9.3% in Q2 2026, buying an estimated $3.22M and bringing the position to 1,095,171 shares worth $44.5M. The position accounts for 2.7% of the portfolio, ranked #16.

First Light Asset Management first reported a position in EWTX in Q4 2024 and has held it in 7 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • First Light Asset Management held 1,095,171 shares of Edgewise Therapeutics worth $44.5M as of Q2 2026.
  • First Light Asset Management bought 93,325 Edgewise Therapeutics shares in Q2 2026, an estimated $3.22M.
  • Edgewise Therapeutics made up 2.7% of First Light Asset Management's portfolio in Q2 2026, its #16 holding.
  • First Light Asset Management first reported a position in Edgewise Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on First Light Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.